We investigated, morphologically and immunohistochemically, 74 medullary adrenal tumors, including 64 pheochromocytomas (14 malignant and 50 benign), 9 ganglioneuromas, and 1 malignant schwannoma. The tumors were detected in 2-year-old Wistar and Sprague-Dawley rats from carcinogenicity studies. Morphologically, benign pheochromocytomas were characterized by monomorphic, small, basophilic cells with almost absence of mitoses. Malignant pheochromocytomas presented a low grade of pleomorphism, higher rate of mitoses, necrosis, infiltrative growth and in 1 case metastases in the lung. Ganglioneuromas were characterized by ganglion and neuron-like cells embedded in an eosinophilic matrix containing neurites, Schwann cells, and scant fibrovascular elements. All pheochromocytomas were strongly immunoreactive for tyrosine hydroxylase (TH), the rate-limiting enzyme in catecholamine synthesis. Subpopulations of chromaffin cells expressed chromogranin A (CGA) positivity. Matrix and Schwann cells were positive for S-100 and for glial fibrillary acidic protein (GFAP). In focal areas of the tumors, ganglion cells and axons were positive for neurofilament proteins (NFP) and synaptophysin. Ganglion cells exhibited peripherin and ß-tubulin. Proliferative activity of the tumors was assessed by immunostaining the endogenous cell proliferation associated-antigen Ki-67 and the proliferating cell nuclear antigen (PCNA). As expected, cell proliferation indeces were much higher in malignant pheochromocytomas than in benign, yet ganglioneuromas remained immunonegative. Considering that Ki-67 antigen is more specific for cell proliferation, it should be regarded as marker of choice for supporting the differential diagnosis between benign and malignant pheochromocytomas.
INTRODUCTION
Spontaneous proliferative lesions of the adrenal medulla are common in aging rats. These lesions, which include diffuse hyperplasia, nodular hyperplasia, and pheochromocytoma, occur most frequently in male rats, with reported frequency of over 80% in the Wistar strain and over 30% in the Fischer 344 and Sprague-Dawley strains (29) . Chronic treatment with xenobiotics, such as the antihypertensive drug reserpine and vitamin D3, stimulates chromaffin cell proliferation and induces pheochromocytomas in rats (30, 31, 32, 36) . Ganglioneuromas of the adrenal medulla have been reported as rare tumors in the Wistar, Fisher 344, and Sprague-Dawley strains and are usually associated with pheochromocytomas. In human beings, the association between pheochromocytoma and ganglioneuroma of the adrenal medulla has also been observed (3) . The adrenal medulla derives from the neural crest and consists of 3 types of cells: chromaffin, neuronal (ganglion-like), and sustentacular cells (6, 10) . Chromaffin and ganglion-like cells are descendent from a common sympathoadrenal neuroblastic precursor (34) , express neuronal cytoskeletal proteins and exhibit catecholaminergic properties. Sustentacular cells are stromal or supportive cells and possess morphologic, functional, and antigenic properties similar to those of Schwann and satellite cells. In rats, there are 3 types of chromaffin cells: epinephrine cells (the majority), norepinephrine cells, and small granule-containing cells (5, 26) . Human chromaffin cells contain both norepinephrine and epinephrine within a single cell.
The objective of the present investigation was to better characterize immunohistologically a large number of medullary tumors in rats using-in addition to the traditional markers such as SY-38, NFP, TH, and CGA-novel markers such as ß III tubulin, peripherin, as well as proliferation markers (PCNA and Ki-67) that, to the best of our knowledge, have never been used before in assessing adrenal medullary neoplasms in rodents.
Widely used immunohistochemical markers for characterizing medullary tumors were also applied in the present study: TH and CGA for pheochromocytes, S-100 and GFAP for sustentacular cells, NFP and SY-38 for ganglion cells. In addition, novel markers such as ß III tubulin and peripherin were tested for the first time in rat adrenal medullary tumors. Because previous studies on cell proliferation in man have shown that Ki-67 is superior to PCNA (16, 35) , we assessed cell proliferation in rat adrenal medullary tumors using both markers in order to select a reference marker for future investigations in this field.
MATERIALS AND METHODS
Tumor specimens were obtained from 2-year carcinogenicity studies conducted in compliance with estabilished principles of good laboratory practices (GLP) in several European pharmaceutical laboratories, principally located in Germany and Switzerland. Animal care and handling procedures were carried out in complete accordance with the laws on animal protections of the respective countries. The tumor series, all taken from control animals, included males and females of the Wistar and Sprague-Dawley strains. Adrenal glands were fixed by immersion in 10% buffered formalin, dehydraded in a graded ethanol series, and embedded in paraffin wax. Serial sections were cut at 4-5-micrometer thickness and either stained with hematoxylin and eosin (H&E) or used for immunohistochemistry. Immunohistochemical reactions (Tables 1 and 2) were performed using either the streptavidin/peroxidase (StreptABC/HRP) or the immunoperoxidase (PAP) methods with the following rabbit polyvalent (pAb) and mouse monoclonal (mAb) antibodies: (1) antityrosine hydroxylase (TH) mAb (Zymed Laboratories Inc, So San Francisco, CA, USA, lot 00350511, diluted 1:50); (2) antiglial fibrillary acidic protein (GFAP) pAb (Dako Diagnostic AG, Zug, Switzerland, lot 119, diluted 1:1200); (3) antineurofilament protein 200-kD subunit (NFP) mAb (Sigma Biosciences, St. Louis, MO, USA, lot 056H4812, diluted 1:2000); (4) TUJ1 mAb, which recognizes an epitope on the class III beta-tubulin isotype (courtesy of Dr A Frankfurter, University of Virginia School of Medicine, Department of Biology, Charlottesville, VA, USA, diluted 1:800) (18); (5) anti-S-100 protein (S-100) pAb (Dako, lot 129, diluted 1:1200); (6) anti-synaptophysin (SY-38) mAb (Dako, lot 016, diluted 1:100); (7) antichromogranin A (CGA) pAb (Dako, lot 072, diluted 1:800); (8) antiperipherin mAb (Novocastra, Readysistem AG, BAD Zurzach, Switzerland, lot 129401, diluted 1:200); (9) antiproliferating cells Ki-67 mAb (MIB-5 Immunotech, Milan Analytica AG, La Roche, Switzerland, lot 1297, diluted 1:1200); and (10) antiproliferating cell nuclear antigen (PCNA) mAb (PC10, Dako, lot 043, diluted 1:10,000. All sections were deparaffinized in xylene, rehydrated through graded ethanol, and endogenous peroxidase activity was blocked with hydrogen peroxide (0.5% in methanol for 30 minutes). Sections prepared for beta-tubulin, synaptophysin 38 (SY-38), chromogranin A (CGA), peripherin, Ki-67, and PCNA antibody immunoreactions were placed in a Coplin jar containing an antigen retrieval solution (Biogenex, San Ramon, CA, USA) and heated 8 × 5 minutes in a microwave processor at 95 • C. Primary antibodies were applied for 18-22 hours. For the StreptABC/HRP method, which was used for antibodies 1-4, biotinylated goat anti-mouse/rabbit immunoglobulins (Dako, lot 068, diluted 1:100), and StreptABComplex/HRP (Dako, lot 068, diluted 1:100), were successively applied at room temperature (RT) for 25 minutes each. For the PAP method, which was used with the S-100 pAb, swine anti-rabbit immunoglobulins (Dako, lot 043/501, diluted 1:50) and rabbit PAP-complex (Dako, lot 082/201, diluted 1:200) were applied at RT for 15 and 20 minutes, respectively. The immunohistochemical reactions were developed in freshly prepared 3,3 -diaminobenzidine tetrahydrochloride (Amersham Laboratories, Buckinghamshire, UK), 10 mg in 13 ml of 0.05 M Tris buffer containing 0.015% of hydrogen peroxide, 1-10 minutes at RT. As positive controls, sections from rat adrenal (for Sy-38 and chromogranin A), brain (for GFAP), small intestine (for NFP, S-100, peripherin, Ki-67, and PCNA), and testis (for beta-tubulin) were immunostained in parallel. Negative controls were obtained by omitting the primary antibodies.
All sections were re-examined by 3 experienced pathologists and classified as pheochromocytomas (64), mixed ganglioneuromas (9), and schwannoma (1) . Because of the lack of tissue availability, cell proliferation was assessed in 15 tumors only (9 benign, 4 malignant pheochromocytomas, and 2 ganglioneuromas) using Ki-67 and PCNA. The proliferating index (PI) was defined as the percentage of labeled cells divided by the total number of cells. A range between 1,200 and 1,800 of total number of cells (labeled and unlabeled cells together) were counted for each tumor. Tumor size (mm) was determined by measurement of the 2 greatest tumor dimensions in H&E sections using a Zeiss microbar (1 mm) under the light microscope. The Student's t-test ( p < 0.05) was used for parametric comparisons (2-group comparisons) between benign and malignant pheochromocytomas.
RESULTS

Histology
The incidence of the adrenal medullary tumors observed in the present study, which included male and female Wistar and Sprague-Dawley rats, is reported in Table 3 . Morphologically, benign pheochromocytomas varied in size. They appeared monomorphic with smaller and more basophilic cells compared to adjacent chromaffin cells, with higher nuclear/cytoplasmic ratio and clumped chromatin. Cells were usually arranged in nests or less frequently in trabeculae ( Figure 1 ), yet mitoses were rare. Fourteen additional pheochromocytomas were classified as malignant on the basis of their morphological features, including pronounced cortical infiltration and invasion, trabecular or solid pattern, 494 PACE ET AL TOXICOLOGIC PATHOLOGY pleomorphic cells with prominent nuclei, presence of numerous mitoses, apoptosis, necrosis, hemorrhages, cystic spaces, and high grade of proliferative activity assessed by Ki-67 and PCNA antigens. One of these malignant tumors metastasized in the lung (Figures 2-5 ).
Ganglioneuromas were always associated with pheochromocytomas and in large tumors, hemorrhages and necroses were often present ( Figure 6 ). They consisted of welldifferentiated ganglion cells intermingled with satellite and Schwann cells and embedded in an eosinophilic neurofibrillary matrix arranged in bundles and/or fascicles resembling neurofibromas ( Figure 7 ). The multipolar ganglion cells varied in size and had abundant acidophilic or slightly basophilic finely granular cytoplasm. The large round or ovoid vesicular nuclei with dispersed chromatin were located eccentrically in the cytoplasm and had 1 or more prominent nucleoli ( Figure 7) . In contrast, the pheochromocytoma cells were small and more uniform and resembled normal, but smaller and more basophilic, chromaffin cells. Intermediate cells, expressing morphological features of both chromaffin cells and ganglion cells to varying degrees were also present. They tended to be larger than the typical chromaffin cells, with irregular borders and contained nucleus with coarse chromatin and 1 to several small nucleoli ( Figure 6 ). Scattered ganglion and intermediate cells were present within areas of the pheochromocytoma. Only 1 malignant schwannoma occupying the adrenal medulla and infiltrating the adrenal cortex was found in our series (Figures 8, 9) .
Immunohistochemistry
The main immunohistochemical findings are summarized in Table 4 . Normal and neoplastic chromaffin cells and intermediate cells in pheochromocytomas stained strongly for TH ( Figure 10 ). Although weak TH positivity was observed in some ganglion cells ( Figure 11 ), ganglion cells and neurites were usually TH negative but expressed ß-III tubulin and peripherin positivity (Figures 12 and 13 ). ß-III tubulin was also present in some chromaffin cells and absent in others (different subpopulations). Fibroblasts, adrenal cortical cells, connective and fat tissue, vascular endothelial cells and smooth muscle were ß-tubulin and peripherin negative. In focal areas of the tumors, ganglion cells and neurites were also positive for neurofilament proteins (NFP) and synaptophysin (Figures 14 and 15 ). Synaptophysin immunoreactivity was also present in some subpopulations of chromaffin cells. Chromogranin A expression varied among different areas in pheochromocytomas ( Figure 16 ) and weak immunostaining was also expressed by ganglion cells. Schwann and sustentacular cells exhibited strong immunoreactivity for S-100 protein and for GFAP ( Figures 17 and 18) .
Results of the cell proliferative index (PI) are reported in Table 5 . All immunoreactive cells, weakly or strongly immunostained for Ki-67 and/or PCNA were considered as being immunopositive. All benign tumors expressed variable degree of immunoreactivity for PCNA, while 3 out of 9 were Ki-67 negative. Some benign pheochromocytomas displayed weak Ki-67 immunoreactivity in a small number of scattered neoplastic cells ( Figure 19 ); smaller neoplastic cells with prominent nuclei reacted the most. PCNA antigen expression ( Figure 21 ) was present in all benign tumors with a PI varying from 1.1 to 13%. Some positivity was also expressed by normal medullary and cortical cells. Three malignant pheochromocytomas ( Figure 20 ) disclosed a Ki-67 proliferative index of 10-15%, yet in these tumors the PCNA reaction ( Figure 22 ) had a higher variability (PI from 11-61%). One malignant tumor, despite the morphological features of malignancy (invasion of cortex, large size, small and dense-packed cells, necrosis and hemorrhages) expressed a lower Ki-67 (6%) and PCNA (13%) PI. Malignant pheochromocytomas correlated well with the tumor size; 50% had a size of about 10 mm, and none was smaller than 3 mm. In contrast, benign pheochromocytomas had a high variability ranging from large (8 × 5 mm) to very small (0.5 × 0.5 mm). 
Ki-67 and PCNA expressions were absent in the ganglion cells of the 2 investigated ganglioneuromas.
DISCUSSION
In the present study, 64 rat pheochromocytomas, 9 mixed ganglioneuromas, and 1 malignant schwannoma were investigated. The series included male and female Wistar and Sprague-Dawley rats. Tumor specimens were retrieved from our archive or provided by other private institutions. In the historical data of spontaneus neoplastic lesions collected in the RITA data base (Registry of Industrial Toxicology Animal Data), spontaneous benign pheochromocytomas in rats have an incidence varying from 8.5% in male and 1.8% in female Sprague-Dawley rats to 11% in male and 3.7% in Wistar rats). Malignant pheochromocytomas had a lower incidence in both strains and ganglioneuromas were very rare ( Table 3) .
Incidences reported in the literature of benign pheochromocytomas range from 4% in male and 0.75% in female Sprague-Dawley rats (5) to 5.7% in male and 0.3% in female Fischer 344 rats (8) . In these strains, malignant pheochromocytomas are extremely rare ranging from 0.82% in male and 0.08% in female Sprague-Dawley (7) to 0.3% in male and 0.1% in female Fischer-344 rats (8) . Metastases were reported in 1 case in the Sprague-Dawley strain and in 1 male and 2 females in the Fischer 344 strain (7, 8) . In a more recent review of Fischer 344 rats used in long-term carcinogenicity studies, pheochromocytomas were observed in 31.9% of male and in 5.1% of female rats used in feedings trials (13) . In contrast, ganglioneuromas of the adrenal are extremely rare in both strains, ranging from 0.07 to 0.1% in males and not reported in females (13) .
Metastases have never been reported in mixed malignant medullary tumors of rats whereas they were described in man (19) . The occurrence of pheochromocytomas in rats can be affected by xenobiotic agents and by different diet regimens. Substances inducing pheochromocytomas in rats are pharmacologically diverse and, in the majority, nongenotoxic (29) . It has been hypothesized that a common denominator in their mode of action is the stimulation of chromaffin cell proliferation by neurally derived signals that also regulate catecholamine production and release. Evidence to support this hypothesis is provided by studies showing that agents associated with development of pheochromocytomas in rats are mitogenic for chromaffin cell in vitro. One of these agents is the antihypertensive drug reserpine (30) which causes pheochromocytomas in rats but not in mice (35) . Adrenal gland denervation inhibits the chromaffin cell proliferation induced by the administration of reserpin (30) . Other agents capable of inducing proliferative lesions in the rat adrenal medulla are vitamin D3, lactose, and xylitol (32, 36) , which act through the alteration of the calcium homeostasis, resulting in cell proliferation of the adrenal medulla. This pathway seems to be common to a number of nongenotoxic compounds that induce pheochromocytomas in rats. Composition of diets may influence growth, diseases, tumor rates and responses to treatment with xenobiotics. High fat and/or fiber in experimental diets decrease the incidence of pheochromocytomas in male Fisher 344 rats (21) . Food restriction results in decreased incidence of pheochromocytomas in rats, but has no effect on the frequency of these tumors in mice (12, 33) .
Ganglioneuromas of the adrenal medulla have been reported as rare tumors in the Wistar, Fisher 344 and Sprague-Dawley strains and are usually associated with pheochromocytomas. In a previous investigation with more than 60,000 rats (22), 28 ganglioneuromas were reported, all associated with pheochromocytomas. In such association the term of "tumor medullary benign, complex type" was proposed (23) .
In the present study, we investigated the proliferative activity in a number of benign and malignant pheochromocytomas, and in ganglioneuromas using antibodies against Ki-67 and PCNA antigens. Many previous studies have shown that Ki-67 as a marker for cell proliferation is superior to PCNA (4, 25, 28) . In our investigation, we detected a positive correlation between Ki-67 expression and malignancy in pheochromocytomas (PI > 10% in 3 of 4 malignant tumors). Lower values were recorded in benign pheochromocytomas (PI ranged between 0 to 3.6% with a mean value of 1.7%). Ki-67 also correlated well with the size of the tumors: malignant tumors were bigger than benign ( Table 5 ). It thus appears that high Ki-67 expression (PI > 6%) can be highly indicative of malignancy.
Our results are in accordance with those reported in man (4, 20) , where a cutoff value of Ki-67 labeling of greater than 3% yelded a sensitivity of 50% in predicting malignancy in pheochromocytomas (9) . This difference in Ki-67 labeling values between rats and man can be species-specific, rodents display higher metabolic activity in normal and neoplastic conditions. In 2 out of 4 malignant pheochromocytomas, the large number of cells immunostained for Ki-67 was used as final criterion to classify these tumors as malignant. According to our results, Ki-67 antigen expression appeared to be a reliable marker for diagnosing malignancy in pheochromocytomas. The correlation between PCNA expression and malignant potential was not clearly disclosed in all malignant tumors. Two benign pheochromocytomas had PI values rather similar to those classified as malignant (on the basis of clear morphological Vol. 30 features), yet one malignant had a very high PI (Table 5) . This difference in expression of Ki-67 and PCNA was somewhat unexpected, because both antigens are expressed during the same phases of the cell cycle. However, a review of the literature, in addition to our personal experience with other proliferative lesions, has indicated that PCNA expression in tumors is variable (4, 25, 28) . The main reason seems to be that PCNA can persists in the cells even after the mitotic phase throughout the resting phase (G0) and, therefore, may overestimate proliferative activity. A further confirmation to this hypothesis is that in this study, PCNA expression was often present at a certain extent in normal pheochromocytes and in normal adrenal cortical cells. In contrast Ki-67 expression was rarely and focally present in these cells. Ki-67 and PCNA labeling was absent in the ganglion cells of ganglioneuromas, and this is consistent with the cell postulated status of terminally differentiated derivates of chromaffin cell precursor.
To our knowledge, this is the first time that the presence of class III ß-tubulin and peripherin immunoreactivity were investigated in rat pheochromocytomas and ganglioneuromas. Class III ß-tubulin is a neuron-specific tubulin isotype that is present at the earliest stage of neuronal differentiation and remains throughout the life of the central and peripheral Vol. 30, No. 4, 2002 PHEOCHROMOCYTOMAS AND GANGLIONEUROMAS IN RATS 499 neurons. Whereas, peripherin is a type III neuron-specific intermediate filament protein abounding in the neural crestderived element of the peripheral nervous system. Because ß-tubulin and peripherin are expressed in human neuroectodermal and neural crest-derived neoplasms (11, 14, 18) , we considered important to examine the expression of these neuron-associated proteins in rat pheochromocytomas and ganglioneuromas originating in the adrenal medulla. Immunoreactivity for the ß-tubulin antigen was present in the neoplastic ganglion cells, in subpopulations of neoplastic chromaffin cells and in neurites. The immunostaining was particularly intense in neurites and less pronounced in the ganglion and chromaffin cells (the lesser). Several sparse ganglion cells did not show ß-tubulin or peripherin immunostainings, perhaps because of autolysis or degeneration of those cells. As expected, fibroblasts, adrenal cortical cells, connective and fat tissue, vascular endothelial cells and smooth muscle, were ß-tubulin and peripherin negative. The present immunohistochemical findings are in accordance with previously reported data concerning the human adrenal (14, 17) . Pheripherin immunostaining was present in the cytoplasm of ganglion cells, neurites, intermediate cells and focally in a few pheochromocytes. In agreement with previous reports in human adrenal medullary tumors (15) , sustentacular and Schwann cells were immunoreactive for GFAP and S-100 protein.
The neurofilament protein (NFP 200 kD) was positive in ganglion cells and neurites. Synaptophysin was positive in the ganglion cells and in some subpopulations of chromaffin cells, whereas sustentacular and Schwann cells were negative. Chromogranin A (CGA) was expressed in groups of chromaffin cells and weak chromogranin A immunoreactivity was found in ganglion cells. This observation provides a further evidence that chromaffin and ganglion cells derive from a common precursor cell, the sympathoadrenal neuroblastic precursor (34) . Thus, mutations occuring in stem cells could give rise to both type of tumors, ie, pheochromocytomas and/or ganglioneuromas. Further evidence of the common origin of chromaffin and ganglion cells has been also supported by other reports indicating that nerve growth factor (NGF) induces the transformation of chromaffin cells into neuronal cells with well-developed neurites throughout the adrenal cortex (1) . Furthermore, all pheochromocytomas showed immunoreactivity for TH with sparse ganglion cells also slightly positive. TH immunostaining was more widespread and more intense than the CGA immunostaining. This difference between TH and CGA expression is probably due to the fact that TH, being the rate-limiting enzyme in catecholamine synthesis, is present in all chromaffin cells, even in the less differentiated malignant pheochromocytes. On the other hand, CGA expression depends on the cellular content of secretory granules and, therefore, CGA immunoreactivity is dependent on the grade of differentiation and maturation of pheochromocytes.
We found that ganglioneuromas were composed of ganglion cells and supporting cells, consisting of Schwann cells and satellite cells; the latter, in some tumors, formed a large mass of supporting tissue resembling schwannomas or neurofibromas. Some authors (2) suggested that Schwann cells in neuroblastomas and ganglioneuromas are of reactive origin rather than neoplastic; therefore, it seems that the neuronal cells are the transformed phenotypes and the glial cells are the reactive or stromal cells that may, however, contribute to the process of neuronal differentiation. Neuronal-glial interactions have been observed in the differentiation of primary human adrenal neuroblastomas, ganglioneuroblastomas, and ganglioneuromas (16) , as well as in primary pheochromocytomas originating in the adrenal medulla (14) .
In humans, the association between ganglioneuromas and pheochromocytomas of the adrenal medulla is known to occur (3) and the majority of cases exhibit a benign biologic behavior, attributed partly to their well-differentiated state (24, 27) . In rats, large ganglioneuromas may cause the death of the animal, although morphologically they possess a benign appearance. In these fatal cases pronounced hemorrhages are often detected within and outside the tumor.
